| Product Name | Linagliptin-d3 |
| Product Code | DA-L057-z |
| Chemical name | Linagliptin-d3 |
| Synonyms | 8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butyn-1-yl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione-d3; 8-[(3R)-3-Amino-1-piperidinyl]-7-(2-butynyl)-3,7-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]-1H-purine-2,6-dione-d3; BI 1356-d3; BI 1356BS-d3; ONDERO-d3 |
| Impurity | NA |
| CAS Number | 1398044-48-8 |
| Alternate CAS # | NA |
| Molecular form | C25H25D3N8O2 |
| Appearance | NA |
| Melting Point | NA |
| Mol. Weight | 475.56 |
| Storage | 2-8°C Refrigerator |
| Solubility | NA |
| Stability | NA |
| Category | amines,aromatics,heterocycles,stable isotopes,pharmaceutical standards,intermediates,fine chemicals |
| Boiling Point | NA |
| Applications | Linagliptin-d3 is the isotope labelled analogue of a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes. |
| Dangerous Goods Info | NA |
| References | NA |
| Extra Notes | NA |
| Documents (MSDS) | No Data Available |
| Keywords | NA |
